Sign in
SCHEDULE 13G

Statement of Beneficial Ownership

Cadrenal Therapeutics, Inc. Filed Acc 0002163771-26-000002

Stakes reported in this filing

Reporting person Shares Of the class
Baggett Benjamin Matthew Wall 300,000 7.3%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…